TAKEDA PHARMACEUTICAL CO LTD (TAK) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-06 | 6-K | — | SEC |
| 2026-07-30 | 6-K | — | SEC |
| 2026-07-09 | 6-K | — | SEC |
| 2026-07-08 | 6-K | — | SEC |
| 2026-06-29 | 6-K | — | SEC |
| 2026-06-26 | 6-K | — | SEC |
| 2026-06-24 | 6-K | — | SEC |
| 2026-06-24 | 6-K | — | SEC |
| 2026-06-24 | 6-K | — | SEC |
| 2026-06-09 | 6-K | — | SEC |
| 2026-06-05 | 6-K | — | SEC |
| 2026-06-05 | 6-K | — | SEC |
| 2026-06-01 | 6-K | — | SEC |
| 2026-05-26 | 6-K | — | SEC |
| 2026-05-26 | 6-K | — | SEC |
| 2026-05-26 | 6-K | — | SEC |
| 2026-05-26 | 6-K | — | SEC |
| 2026-05-26 | 6-K | — | SEC |
| 2026-05-19 | 6-K | — | SEC |
| 2026-05-13 | 6-K | — | SEC |
| 2026-05-13 | 6-K | — | SEC |
| 2026-03-30 | 6-K | — | SEC |
| 2026-03-26 | 6-K | — | SEC |
| 2026-03-25 | 6-K | — | SEC |
| 2026-03-02 | 6-K | — | SEC |
| 2026-02-10 | 6-K | — | SEC |
| 2026-01-29 | 6-K | — | SEC |
| 2025-12-18 | 6-K | — | SEC |
| 2025-12-08 | 6-K | — | SEC |
| 2025-11-28 | 6-K | — | SEC |
| 2025-10-30 | 6-K | — | SEC |
| 2025-10-30 | 6-K | — | SEC |
| 2025-10-30 | 6-K | — | SEC |
| 2025-10-01 | 6-K | — | SEC |
| 2025-09-25 | 6-K | — | SEC |
| 2025-09-08 | 6-K | — | SEC |
| 2025-07-31 | 6-K | — | SEC |
| 2025-07-30 | 6-K | — | SEC |
| 2025-07-14 | 6-K | — | SEC |
| 2025-07-09 | 6-K | — | SEC |
| 2025-07-08 | 6-K | — | SEC |
| 2025-07-02 | 6-K | — | SEC |
| 2025-07-01 | 6-K | — | SEC |
| 2025-06-30 | 6-K | — | SEC |
| 2025-06-25 | 6-K | — | SEC |
| 2025-06-25 | 6-K | — | SEC |
| 2025-06-12 | 6-K | — | SEC |
| 2025-06-10 | 6-K | — | SEC |
| 2025-06-06 | 6-K | — | SEC |
| 2025-06-02 | 6-K | — | SEC |
| 2025-06-02 | 6-K | — | SEC |
| 2025-05-28 | 6-K | — | SEC |
| 2025-05-28 | 6-K | — | SEC |
| 2025-05-28 | 6-K | — | SEC |
| 2025-05-28 | 6-K | — | SEC |
| 2025-05-14 | 6-K | — | SEC |
| 2025-05-08 | 6-K | — | SEC |
| 2025-05-08 | 6-K | — | SEC |
| 2025-04-22 | 6-K | — | SEC |
| 2025-04-14 | 6-K | — | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.